Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-CD8 alpha Antibody-APC (6L958)

🥰Excellent
Catalog No. TMAY-01409A

Anti-CD8 alpha Antibody-APC (6L958) is a APC-conjugated Mouse antibody targeting CD8 alpha. Anti-CD8 alpha Antibody-APC (6L958) can be used in FCM.

Anti-CD8 alpha Antibody-APC (6L958)

Anti-CD8 alpha Antibody-APC (6L958)

🥰Excellent
Catalog No. TMAY-01409A
Anti-CD8 alpha Antibody-APC (6L958) is a APC-conjugated Mouse antibody targeting CD8 alpha. Anti-CD8 alpha Antibody-APC (6L958) can be used in FCM.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View More
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Anti-CD8 alpha Antibody-APC (6L958) is a APC-conjugated Mouse antibody targeting CD8 alpha. Anti-CD8 alpha Antibody-APC (6L958) can be used in FCM.
Ig Type
Monoclonal Mouse IgG2b
Clone
6L958
Reactivity
Human
Verified Activity
Flow cytometric analysis of Human CD8a expression on human whole blood lymphocytes. Cells were stained with APC-conjugated anti-Human CD8a. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes.
Application
FCM
Recommended Dose
2 μl/Test, 0.1 mg/ml
Antibody Type
Monoclonal
Host SpeciesMouse
ConstructionThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD8 alpha/CD8A (rh CD8 alpha/CD8A; NP_001759.3Met1-Asp182) and conjugated with APC under optimum conditions, the unreacted APC was removed.
PurificationProtein A
AppearanceLiquid
FormulationPBS solution containing 0.5% BSA and 0.03%ProClin300
Research BackgroundT-cell surface glycoprotein CD8 alpha chain, also known as CD8a, is a single-pass type I membrane protein. The CD8 glycoprotein is expressed by thymocytes, mature T cells and natural killer (NK) cells and has been implicated in the recognition of monomorphic determinants on major histocompatibility complex (MHC) Class I antigens, and in signal transduction during the course of T-cell activation. Both human and rodent CD8 antigens are comprised of two distinct polypeptide chains, alpha and beta. The Ig domains of CD8 alpha are involved in controlling the ability of CD8 to be expressed. Mutation of B- and F-strand cysteine residues in CD8 alpha reduced the ability of the protein to fold properly and, therefore, to be expressed. Defects in CD8A are a cause of familial CD8 deficiency. Familial CD8 deficiency is a novel autosomal recessive immunologic defect characterized by absence of CD8+ cells, leading to recurrent bacterial infections.
Related Conjugates and Formulations
Conjucates
APC
Others Formats
Unconjugated/PerCP/FITC/PE
Antibody Types Available
5
Antigen Details
Immunogen
Recombinant Human CD8 alpha/CD8A Protein
Antigen Species
Human
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight.
TransportShipping with blue ice.

Sci Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-CD8 alpha Antibody-APC (6L958) | purchase Anti-CD8 alpha Antibody-APC (6L958) | Anti-CD8 alpha Antibody-APC (6L958) cost | order Anti-CD8 alpha Antibody-APC (6L958)